Markus Jäger
Medizinisch-technischer Assistent
Hat mitgewirkt an:
-
Untersuchungen zu der antiproliferativen Wirkung von Vetiveracetat auf den Zellstoffwechsel von Brustkrebs in vitro
-
HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer
-
Endoxifen and fulvestrant regulate estrogen-receptor [alpha] and related DEADbox proteins
-
Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker